Hot Features
Premium
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Período:
Tipo de Línea:
| Volume | 143,631 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 4.20 | Mínimo Máximo |
|||||
| Minimo del Dia | 3.90 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Monte Rosa Therapeutics Inc | GLUE | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4.12 | 15:02:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 4.16 | 3.90 | 4.20 | 4.12 | 4.12 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 1,684 | 143,631 | US$ 4.08 | US$ 585,867 | - | 2.44 - 8.84 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 15:02:46 | priorref | 628 | US$ 4.12 | USD |
Información Financiera Monte Rosa Therapeutics Inc GLUE
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 206.63M | 50.15M | - | 0 | -135.35M | -2.70 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Monte Rosa Therapeutics Inc GLUE
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 30/5/2024 | 06:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 30/5/2024 | 06:00 | GlobeNewswire Inc. | Monte Rosa Therapeutics Announces Leadership Team Promotions |
| 21/5/2024 | 06:00 | GlobeNewswire Inc. | Monte Rosa Therapeutics Presents Preclinical Data at.. |
| 16/5/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16/5/2024 | 15:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 16/5/2024 | 06:00 | GlobeNewswire Inc. | Monte Rosa Therapeutics Announces Pricing of $100 Million.. |
| 15/5/2024 | 15:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 15/5/2024 | 15:01 | GlobeNewswire Inc. | Monte Rosa Therapeutics Announces Proposed Public Offering.. |
| 09/5/2024 | 06:45 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09/5/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/5/2024 | 06:00 | GlobeNewswire Inc. | Monte Rosa Therapeutics Announces First Quarter 2024.. |
| 02/5/2024 | 15:01 | GlobeNewswire Inc. | Monte Rosa Therapeutics Announces the Departure of Owen.. |
Histórico de Datos GLUE
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.02 | 4.335 | 3.90 | 4.13 | 156,253 | 0.10 | 2.49% |
| 1 Month | 5.82 | 6.02 | 3.90 | 4.86 | 238,918 | -1.70 | -29.21% |
| 3 Months | 6.24 | 8.84 | 3.90 | 5.85 | 175,735 | -2.12 | -33.97% |
| 6 Months | 3.16 | 8.84 | 2.92 | 5.43 | 191,092 | 0.96 | 30.38% |
| 1 Year | 6.55 | 8.84 | 2.44 | 5.32 | 201,256 | -2.43 | -37.10% |
| 3 Years | 22.00 | 45.56 | 2.44 | 11.11 | 207,978 | -17.88 | -81.27% |
| 5 Years | 22.00 | 45.56 | 2.44 | 11.11 | 207,978 | -17.88 | -81.27% |
